| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 9257582 | Critical Reviews in Oncology/Hematology | 2005 | 5 Pages |
Abstract
The present review aims at providing a panorama on classical as well as new prognostic markers. Of special interest are some molecular factors, already or currently tested from a prognostic point of view, that might also become good candidates for predicting treatment efficacy.
Keywords
RASSF1ADAPKMMPEGFRTGFHGFtransforming growth factorLungMolecular biologyNon-small cell lung cancer (NSCLC)Hepatocyte growth factorVascular endothelial growth factorVascular Endothelial Growth Factor (VEGF)Prognostic factorsMatrix metalloproteinasesBiomarkersdeath-associated protein kinaseEpidermal growth factor receptor
Related Topics
Health Sciences
Medicine and Dentistry
Hematology
Authors
P. Vielh, J.-P. Spano, J. Grenier, T. Le Chevalier, J.-C. Soria,